BACKGROUND: The mean age at onset of new cases of rheumatoid arthritis (RA) has increased markedly. Because the prevalence of false positive rheumatoid factor reactions increases with advancing age, the diagnostic value of this test has limitations among the aged. OBJECTIVE: To study the occurrence of two filaggrin related antibodies in an aged population. METHODS: The study covered 300 subjects aged 78-88 years, one of whom had RA. The sera were tested with enzyme linked immunosorbent assays (ELISAs), using filaggrin purified from human skin and citrullinated cyclic peptide (CCP) as antigens. RESULTS: One patient with RA was positive for both antibodies. When the cut off level for positive reactions was set at the 98th centile of healthy blood donors, 24 (8%) of the other subjects were positive for antibodies against filaggrin, but only one against CCP. CONCLUSION: The test for anti-CCP antibody has better specificity than the test for antibodies against filaggrin among the aged.
BACKGROUND: The mean age at onset of new cases of rheumatoid arthritis (RA) has increased markedly. Because the prevalence of false positive rheumatoid factor reactions increases with advancing age, the diagnostic value of this test has limitations among the aged. OBJECTIVE: To study the occurrence of two filaggrin related antibodies in an aged population. METHODS: The study covered 300 subjects aged 78-88 years, one of whom had RA. The sera were tested with enzyme linked immunosorbent assays (ELISAs), using filaggrin purified from human skin and citrullinated cyclic peptide (CCP) as antigens. RESULTS: One patient with RA was positive for both antibodies. When the cut off level for positive reactions was set at the 98th centile of healthy blood donors, 24 (8%) of the other subjects were positive for antibodies against filaggrin, but only one against CCP. CONCLUSION: The test for anti-CCP antibody has better specificity than the test for antibodies against filaggrin among the aged.
Authors: Peter Lea; Edward Keystone; Sasi Mudumba; Anthony Kahama; Shi-Fa Ding; Jennifer Hansen; Azar A Azad; Sihe Wang; Deborah Weber Journal: Clin Rev Allergy Immunol Date: 2011-08 Impact factor: 8.667
Authors: Wafaa M Ezzat; Hala M Raslan; Azza A Aly; Nahed A Emara; Manal M El Menyawi; Amr Edrees Journal: Rheumatol Int Date: 2009-11-01 Impact factor: 2.631
Authors: D S Majka; K D Deane; L A Parrish; A A Lazar; A E Barón; C W Walker; M V Rubertone; W R Gilliland; J M Norris; V M Holers Journal: Ann Rheum Dis Date: 2007-11-01 Impact factor: 19.103
Authors: E R Vossenaar; T R D Radstake; A van der Heijden; M A M van Mansum; C Dieteren; D-J de Rooij; P Barrera; A J W Zendman; W J van Venrooij Journal: Ann Rheum Dis Date: 2004-04 Impact factor: 19.103
Authors: S Dubucquoi; E Solau-Gervais; D Lefranc; L Marguerie; J Sibilia; J Goetz; V Dutoit; A-L Fauchais; E Hachulla; R-M Flipo; L Prin Journal: Ann Rheum Dis Date: 2004-04 Impact factor: 19.103
Authors: Jennie Ursum; Wouter H Bos; Rob J van de Stadt; Ben A C Dijkmans; Dirkjan van Schaardenburg Journal: Arthritis Res Ther Date: 2009-05-21 Impact factor: 5.156